Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in Neutralization Assays for SARS‐CoV‐2
Yuying Lu, Wang Jin, Qianlin Li, et al.
Scandinavian Journal of Immunology (2021) Vol. 94, Iss. 3
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study
Ana Atti, Ferdinando Insalata, Edward J Carr, et al.
Journal of Infection (2022) Vol. 85, Iss. 5, pp. 545-556
Open Access | Times Cited: 39
Commercial immunoassays for detection of anti-SARS-CoV-2 spike and RBD antibodies: urgent call for validation against new and highly mutated variants
Giuseppe Lippi, Khosrow Adeli, Mario Plebani
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 60, Iss. 3, pp. 338-342
Open Access | Times Cited: 44
Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern
Dale Kitchin, Simone I. Richardson, Mieke A. van der Mescht, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 3, pp. 100535-100535
Open Access | Times Cited: 35
A comprehensive review on immunogen and immune-response proteins of SARS-CoV-2 and their applications in prevention, diagnosis, and treatment of COVID-19
Daohong Zhang, Deepak Kukkar, Ki‐Hyun Kim, et al.
International Journal of Biological Macromolecules (2024) Vol. 259, pp. 129284-129284
Closed Access | Times Cited: 6
The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality
Yadira Lobaina, Rong Chen, Edith Suzarte, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 418-418
Open Access | Times Cited: 6
Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays
Andrea Padoan, Chiara Cosma, Francesco Bonfante, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 60, Iss. 3, pp. 456-463
Open Access | Times Cited: 38
Antigenic characterization of influenza and SARS-CoV-2 viruses
Yang Wang, Cynthia Y. Tang, Xiu‐Feng Wan
Analytical and Bioanalytical Chemistry (2021) Vol. 414, Iss. 9, pp. 2841-2881
Open Access | Times Cited: 34
Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies
Sun Jin Kim, Zhong Yao, Morgan Marsh, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Development of a Cell-Based SARS-CoV-2 Pseudovirus Neutralization Assay Using Imaging and Flow Cytometry Analysis
Jerilyn R. Izac, Edward Kwee, Linhua Tian, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12332-12332
Open Access | Times Cited: 10
SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assays
Andrea Padoan, Chiara Cosma, Francesco Bonfante, et al.
Clinica Chimica Acta (2021) Vol. 523, pp. 446-453
Open Access | Times Cited: 26
Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera
Petros Eliadis, Annie Mais, Alexandros Papazisis, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 914-914
Open Access | Times Cited: 2
Vaccine Candidate Against COVID-19 Based on Structurally Modified Plant Virus as an Adjuvant
Angelina Kovalenko, Ekaterina M. Ryabchevskaya, Ekaterina A. Evtushenko, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 11
A Systematic Review and Meta-Analysis Comparing the Diagnostic Accuracy Tests of COVID-19
Juan Jeferson Vilca-Alosilla, Mayron Antonio Candia-Puma, Katiusca Coronel-Monje, et al.
Diagnostics (2023) Vol. 13, Iss. 9, pp. 1549-1549
Open Access | Times Cited: 6
Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera
Kelly J. Roper, Jordan Thomas, Wejdan Albalawi, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Genotype–phenotype landscapes for immune–pathogen coevolution
Alief Moulana, Thomas Dupic, Angela M. Phillips, et al.
Trends in Immunology (2023) Vol. 44, Iss. 5, pp. 384-396
Open Access | Times Cited: 5
Enzyme-Linked Immunosorbent Assay: An Adaptable Methodology to Study SARS-CoV-2 Humoral and Cellular Immune Responses
Amanda Izeli Portilho, Gabrielle Gimenes Lima, Elizabeth De Gaspari
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1503-1503
Open Access | Times Cited: 9
Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population
Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, et al.
Journal of Infection and Chemotherapy (2022) Vol. 28, Iss. 9, pp. 1273-1278
Open Access | Times Cited: 9
Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection
Loukia Psaridi, Helena C. Maltezou, Sofia Simonidou, et al.
Vaccine (2022) Vol. 40, Iss. 40, pp. 5752-5756
Open Access | Times Cited: 9
Quantitative and Standardized Pseudovirus Neutralization Assay for COVID-19
Jerilyn R. Izac, Edward Kwee, Adolfas K. Gaigalas, et al.
Methods in molecular biology (2024), pp. 259-271
Closed Access | Times Cited: 1
Exploring immune evasion of SARS-CoV-2 variants using a pseudotyped system
Haixiao Duan, Ershuai Zhang, Ge Ren, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29939-e29939
Open Access | Times Cited: 1
Optimization of Cellular Transduction by the HIV-Based Pseudovirus Platform with Pan-Coronavirus Spike Proteins
Syamala Rani Thimmiraju, María José Villar, Jason T. Kimata, et al.
Viruses (2024) Vol. 16, Iss. 9, pp. 1492-1492
Open Access | Times Cited: 1
Optimization of SARS-CoV-2 Pseudovirion Production in Lentivirus Backbone With a Novel Liposomal System
Gokulnath Mahalingam, Hari Krishnareddy Rachamalla, Porkizhi Arjunan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
Leveraging South African HIV research to define SARS‐CoV‐2 immunity triggered by sequential variants of concern
Jinal N. Bhiman, Penny L. Moore
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 61-75
Open Access | Times Cited: 8
Serum peptidome profiles immune response of COVID-19 Vaccine administration
Wenjia Zhang, Dandan Li, Bin Xu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Targeted photodynamic neutralization of SARS-CoV-2 mediated by singlet oxygen
Ruhui Yao, Jian Hou, Xin Zhang, et al.
Photochemical & Photobiological Sciences (2023) Vol. 22, Iss. 6, pp. 1323-1340
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top